Feasibility review
Map data availability, missingness, cohort size, outcome definitions, and access requirements.
Possible outputData-readiness assessment and analysis scope.
Collaboration
For academic investigators, biotechnology teams, and clinical research groups exploring treatment-response modeling.
A useful collaboration starts with a defined population, treatment, outcome, and decision. We can discuss whether the available data can address the question and what additional evidence would be needed.
Potential collaboration topics
From scope to next steps
Map data availability, missingness, cohort size, outcome definitions, and access requirements.
Possible outputData-readiness assessment and analysis scope.
Specify baseline comparisons, preprocessing, feature selection, and patient-level evaluation.
Possible outputDocumented analysis and a reproducible modeling workflow.
Identify suitable external cohorts, uncertainty estimates, subgroup checks, and limits of intended use.
Possible outputEvaluation report and a plan for further validation.
Scope, deliverables, data access, timelines, and commercial terms are agreed for each project.
A useful first conversation
A short, non-confidential summary is enough to begin.
Start a scientific conversation
Tell us about your research objective, available data, and the decision your study needs to inform.
Discuss a project